...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Phase 1b/2 trial expected to initiate 1Q 2019
Reply New Message
Prev Message Back To Forum Threaded View Next Message

P.one...Did this not trigger a tax liability for you?

"managed to transfer from my RRSP to my TFSA by transferring RRSP to non registered acct and then into TFSA ."

 

Koo

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply